Clinical Trials Logo

Osteoarthritis of the Knee clinical trials

View clinical trials related to Osteoarthritis of the Knee.

Filter by:
  • Terminated  
  • Page 1 ·  Next »

NCT ID: NCT04931667 Terminated - Clinical trials for Osteoarthritis of the Knee

3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Subjects With Osteoarthritis of the Knee

Start date: July 15, 2021
Phase: Phase 3
Study type: Interventional

This study is designed as a 3-year, multicenter, open-label study evaluating the safety, tolerability, and efficacy of intra-articular (IA) Lorecivivint (LOR) in subjects with osteoarthritis of the knee in a real-world setting.

NCT ID: NCT04630262 Terminated - Clinical trials for Osteoarthritis of the Knee

ATTUNE Cementless FB Tibial Base Clinical Study

Start date: May 9, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, non-randomized, single arm observational study. The primary objective of this clinical investigation is to evaluate functional responder rates with an objective performance criteria (OPC) of 85% as measured by the KOOS questionnaire for the first 225 tibia (CR FB and PS FB combined) implanted with the ATTUNE Cementless FB tray (primary and revision procedures) and will be analyzed when these patients have passed the 1 year preferred post-op window.

NCT ID: NCT03956550 Terminated - Pain Clinical Trials

A Study to Examine the Efficacy and Safety of REGN5069 in Patients With Pain Due to Osteoarthritis of the Knee

Start date: May 21, 2019
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to evaluate the efficacy of REGN5069 compared to placebo in patients with pain due to radiographically-confirmed OA of the knee who have a history of inadequate joint pain relief or intolerance to current analgesic therapy. The secondary objectives of the study are: - To characterize the concentrations of functional REGN5069 in serum over time when patients are treated for up to 12 weeks - To assess the safety and tolerability of REGN5069 compared with placebo when patients are treated for up to 12 weeks - To measure levels of anti-drug antibodies (ADAs) against REGN5069 following multiple IV administrations

NCT ID: NCT02885467 Terminated - Clinical trials for Osteoarthritis of the Knee

Nerve Burial for Preventing Neuralgia After Total Knee Arthroplasty

Start date: August 2013
Phase: N/A
Study type: Interventional

This is a randomized study investigating whether identification, ligation, and burial of superficial branches of the saphenous nerve crossing the surgical field during total knee arthroplasty reduces the rate of post-operative anterior knee pain and neuralgia compared to standard total knee arthroplasty.

NCT ID: NCT02228538 Terminated - Clinical trials for Osteoarthritis of the Knee

Total Knee Arthroplasty Functional Outcomes Study Research Design

Start date: October 2013
Phase:
Study type: Observational

The purpose of this study is to obtain patient oriented and clinically oriented physical function outcomes both pre-operatively and post-operatively in patients receiving a total knee arthroplasty.

NCT ID: NCT02079493 Terminated - Clinical trials for Osteoarthritis of the Knee

Prospective Functional Outcome Study of the Knee

PFOSK
Start date: January 2014
Phase:
Study type: Observational

The purpose of this study is to obtain patient-oriented and clinically-oriented physical function outcomes both pre-operatively and post-operatively in patients receiving a total knee arthroplasty .

NCT ID: NCT01899508 Terminated - Clinical trials for Osteoarthritis of the Knee

Virtual Reality for Osteoarthritis Knee Pain Pilot

VROA
Start date: January 2015
Phase: N/A
Study type: Interventional

This study is looking at whether virtual reality combined with pain coping skills training helps reduce pain in people who suffer from OA of the knee. Eligible participants will be asked to come into the study offices for one visit where they will fill out a couple of questionnaires, do some low impact performance tasks and be taught pain coping skills while looking into a 3D virtual reality viewer.

NCT ID: NCT01820650 Terminated - Clinical trials for Osteoarthritis of the Knee

A Prospective, Multicenter Study to Evaluate the ConforMIS iTotal® (CR) Knee Replacement System

Start date: February 2013
Phase:
Study type: Observational

This study is designed to observe the long term clinical outcomes of patient-specific knee arthroplasty in patients with osteoarthritis.

NCT ID: NCT01645709 Terminated - Clinical trials for Osteoarthritis of the Knee

Safety, Tolerability, and Efficacy of IA Verapamil in the Treatment of Joint Pain in Subjects With Osteoarthritis of the Knee

Start date: April 2012
Phase: Phase 1/Phase 2
Study type: Interventional

This is a randomized, double-blind, placebo-controlled, multi-center study to evaluate the safety, tolerability, and efficacy of Intra-Articular (IA) verapamil in the treatment of joint pain in patients with knee osteoarthritis (OA). Subjects will discontinue all analgesic medications for the entire duration of the study, except for acetaminophen (taken on an as needed basis at no more than 2 g/day). At visit 2, subjects who meet all entry criteria will be randomized to receive a single injection of IA verapamil or IA placebo at a ratio of 1:1. Treatments will be given with fluoroscopy or ultrasound to confirm needle placement. Subjects will be monitored for blood pressure and heart rate (sitting and standing) for at least 1 hour post-injection. Subjects will be evaluated at weeks 1, 2, 3, 4, 6, 8, and 12 after treatment.

NCT ID: NCT01224522 Terminated - Clinical trials for Osteoarthritis of the Knee

Axial Alignment in Patients Operated Using the Visionaire Patient Matched Cutting Blocks

Visionaire
Start date: March 2011
Phase: Phase 3
Study type: Interventional

- Title: PATIENT-MATCHED INSTRUMENTATION VS. STANDARD INSTRUMENTATION: A RANDOMIZED CLINICAL TRIAL COMPARING POSTOPERATIVE AXIAL ALIGNMENT and COMPONENT POSITION - Short Title: Visionaire Alignment - Methodology: Monocentric, Single Blinded, Randomized Controlled Trial - Study Duration: November 2010 to July 2014 - Study Centres: Leicester General Hospital, United Kingdom (UK)